JW Asset Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

JW Asset Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-73,649	Closed	-$4.59M	–	18
2019 Q1	$4.59M	Hold	73,649	–	–	2.36%	11
2018 Q4	$4.46M	Hold	73,649	–	–	3.29%	8
2018 Q3	$4.31M	Hold	73,649	–	–	2.32%	9
2018 Q2	$3.3M	Hold	73,649	–	–	2.11%	11
2018 Q1	$3.27M	Hold	73,649	–	–	3.22%	9
2017 Q4	$3.19M	Hold	73,649	–	–	3.4%	9
2017 Q3	$3.43M	Hold	73,649	–	–	2.51%	11
2017 Q2	$3.65M	Hold	73,649	–	–	2.32%	10
2017 Q1	$40.4M	Hold	73,649	–	–	8.4%	3
2016 Q4	$4.1M	Buy	73,649 +1,000	+1%	+$48.1K	2.73%	9
2016 Q3	$3.32M	Hold	72,649	–	–	2.28%	11
2016 Q2	$2.9M	Hold	72,649	–	–	2.31%	12
2016 Q1	$2.53M	Hold	72,649	–	–	1.65%	17
2015 Q4	$3.12M	Sell	72,649 -937	-1%	-$46.9K	1.16%	19
2015 Q3	$3.2M	Buy	73,586 +12,029	+20%	+$649K	1.16%	20
2015 Q2	$3.18M	Buy	+61,557	New	+$2.62M	0.97%	19

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JW Asset Management's BSTC Position: Q2 2019 in Review

JW Asset Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q2 2019, closing a stake of 73,649 shares — an estimated $4.59M sold.

JW Asset Management first reported a position in BSTC in Q2 2015 and held it in 16 quarters. The position peaked at $40.4M in Q1 2017. 114 funds tracked by Wall St. Rank hold BSTC as of Q2 2019.

JW Asset Management reported no remaining BioSpecifics Technologies Corp. position as of Q2 2019 after selling out during the quarter.
JW Asset Management sold 73,649 BioSpecifics Technologies Corp. shares in Q2 2019, an estimated $4.59M.
JW Asset Management first reported a position in BioSpecifics Technologies Corp. in Q2 2015 and held it in 16 quarters.
JW Asset Management's BioSpecifics Technologies Corp. position peaked at $40.4M in Q1 2017.
114 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q2 2019.

Based on JW Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.